The global medical hyperbaric oxygen chamber market continues to expand, with the core driving forces coming from ‘demand-side expansion, technological iteration, and resonance between policies and payment.’ On the demand side, population aging combined with a surge in chronic diseases has resulted in the patient base for indications such as diabetic foot, post-stroke sequelae, and radiation injuries exceeding 32 million cases per year by 2025, directly driving the rigid demand for hyperbaric oxygen therapy in hospitals and primary care institutions. Data shows that in 2024, the global medical hyperbaric oxygen chamber market size is approximately $389 million.
In recent years, hyperbaric oxygen chambers, as a medical device, have gradually received high attention from the national government, which has introduced a series of policies and measures to promote the development of the hyperbaric oxygen chamber industry. The”Action Plan for Promoting Large-Scale Equipment Upgrades and the Replacement of Consumer Goods”points out: strengthening the construction of a high-quality and efficient medical and health service system, promoting the upgrading of equipment and informatization facilities in medical and health institutions, and encouraging medical institutions with the necessary conditions to accelerate the updating and transformation of medical equipment such as medical imaging, radiation therapy, telemedicine, and surgical robots.
From the perspective of the regional distribution of the global medical hyperbaric oxygen chamber industry, Asia occupies the main market share, accounting for 52.01%, followed by North America at 18.78%, Europe at 17.96%, and other regions at 11.25%.